155 related articles for article (PubMed ID: 27429042)
1. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.
Jové M; Gatius S; Yeramian A; Portero-Otin M; Eritja N; Santacana M; Colas E; Ruiz M; Pamplona R; Matias-Guiu X
Oncotarget; 2016 Aug; 7(32):52364-52374. PubMed ID: 27429042
[TBL] [Abstract][Full Text] [Related]
2. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
[TBL] [Abstract][Full Text] [Related]
4. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
5. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma.
Geels YP; Pijnenborg JM; Gordon BB; Fogel M; Altevogt P; Masadah R; Bulten J; van Kempen LC; Massuger LF
Pathol Oncol Res; 2016 Oct; 22(4):863-8. PubMed ID: 26891628
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of ADAM19 in endometrial carcinoma].
Ou Qz; Zhang Y; Yu L; Dong Y; Zhu C; Liao Qp
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):165-9. PubMed ID: 18458692
[TBL] [Abstract][Full Text] [Related]
7. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
8. A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry.
Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X
Hum Pathol; 2014 Dec; 45(12):2394-403. PubMed ID: 25282036
[TBL] [Abstract][Full Text] [Related]
9. Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences.
Gatius S; Cuevas D; Fernández C; Roman-Canal B; Adamoli V; Piulats JM; Eritja N; Martin-Satue M; Moreno-Bueno G; Matias-Guiu X
Pathobiology; 2018; 85(1-2):35-40. PubMed ID: 28614814
[TBL] [Abstract][Full Text] [Related]
10. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of glypican 3 in endometrial carcinoma and correlation with prognostic parameters.
Hakim SA; Raboh NM
Int J Clin Exp Pathol; 2015; 8(10):13225-32. PubMed ID: 26722522
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
13. RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.
Lemetre C; Vieites B; Ng CK; Piscuoglio S; Schultheis AM; Marchiò C; Murali R; Lopez-García MA; Palacios JC; Jungbluth AA; Terracciano LM; Reis-Filho JS; Weigelt B
Eur J Cancer; 2016 Sep; 64():149-58. PubMed ID: 27420608
[TBL] [Abstract][Full Text] [Related]
14. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma.
Planagumà J; Gonzalez M; Doll A; Monge M; Gil-Moreno A; Baró T; García A; Xercavins J; Alameda F; Abal M; Reventós J
Hum Pathol; 2006 Aug; 37(8):1050-7. PubMed ID: 16867868
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of adiponectin receptors are decreased in human endometrial adenocarcinoma tissues.
Yamauchi N; Takazawa Y; Maeda D; Hibiya T; Tanaka M; Iwabu M; Okada-Iwabu M; Yamauchi T; Kadowaki T; Fukayama M
Int J Gynecol Pathol; 2012 Jul; 31(4):352-7. PubMed ID: 22653349
[TBL] [Abstract][Full Text] [Related]
17. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
Wu HW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
[No Abstract] [Full Text] [Related]
18. Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules.
Wani Y
Histopathology; 2009 Mar; 54(4):495-7. PubMed ID: 19309406
[No Abstract] [Full Text] [Related]
19. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of Twist1 and MMP-2 in endometrial endometrioid adenocarcinoma].
Wang XJ; Chen XH
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):588-91. PubMed ID: 23158991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
